Sinopharm Group Co. Ltd. SHTDY Stock
Sinopharm Group Co. Ltd. Price Chart
Sinopharm Group Co. Ltd. SHTDY Financial and Trading Overview
| Sinopharm Group Co. Ltd. stock price | 9.75 USD |
| Previous Close | 9.79 USD |
| Open | 9.68 USD |
| Bid | 9.69 USD x 191700 |
| Ask | 9.74 USD x 480000 |
| Day's Range | 9.68 - 9.72 USD |
| 52 Week Range | 9.54 - 14.87 USD |
| Volume | 18.8K USD |
| Avg. Volume | 133.7K USD |
| Market Cap | 6.05B USD |
| Beta (5Y Monthly) | 0.437 |
| PE Ratio (TTM) | 5.7337275 |
| EPS (TTM) | 1.69 USD |
| Forward Dividend & Yield | 0.5 (5.19%) |
| Ex-Dividend Date | June 24, 2026 |
| 1y Target Est | N/A |
SHTDY Valuation Measures
| Enterprise Value | 107.46B USD |
| Trailing P/E | 5.7337275 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | 2.26 |
| Price/Sales (ttm) | 0.010574527 |
| Price/Book (mrq) | 0.47637874 |
| Enterprise Value/Revenue | 0.188 |
| Enterprise Value/EBITDA | 5.708 |
Trading Information
Sinopharm Group Co. Ltd. Stock Price History
| Beta (5Y Monthly) | 0.437 |
| 52-Week Change | -20.37% |
| S&P500 52-Week Change | 15.74% |
| 52 Week High | 14.87 USD |
| 52 Week Low | 9.54 USD |
| 50-Day Moving Average | 10.61 USD |
| 200-Day Moving Average | 12.04 USD |
SHTDY Share Statistics
| Avg. Volume (3 month) | 133.7K USD |
| Avg. Daily Volume (10-Days) | 139.58K USD |
| Shares Outstanding | 268.36M |
| Float | 254.92M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | 445.00% |
| Payout Ratio | 0.3008 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 1.23% |
| Operating Margin (ttm) | 3.00% |
| Gross Margin | 7.06% |
| EBITDA Margin | 3.29% |
Management Effectiveness
| Return on Assets (ttm) | 2.56% |
| Return on Equity (ttm) | 8.03% |
Income Statement
| Revenue (ttm) | 571.92B USD |
| Revenue Per Share (ttm) | 916.39 USD |
| Quarterly Revenue Growth (yoy) | -1.60% |
| Gross Profit (ttm) | 40.4B USD |
| EBITDA | 18.83B USD |
| Net Income Avi to Common (ttm) | 7.09B USD |
| Diluted EPS (ttm) | 1.69 |
| Quarterly Earnings Growth (yoy) | -0.89% |
Balance Sheet
| Total Cash (mrq) | 31.04B USD |
| Total Cash Per Share (mrq) | 49.74 USD |
| Total Debt (mrq) | 81.32B USD |
| Total Debt/Equity (mrq) | 59.64 USD |
| Current Ratio (mrq) | 1.399 |
| Book Value Per Share (mrq) | 20.340958 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Sinopharm Group Co. Ltd.
| Country | United States |
| State | N/A |
| City | Shanghai |
| Address | Sinopharm Group Building |
| ZIP | 200023 |
| Phone | 86 21 2305 2666 |
| Website | https://www.sinopharmgroup.com.cn |
| Industry | Medical Distribution |
| Sector(s) | Healthcare |
| Full Time Employees | 90447 |
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices Distribution segment distributes medical devices, as well as provides installation and maintenance services. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the distribution of laboratory supplies; manufacture and distribution of chemical reagents; and production and sale of pharmaceutical products. The company rents and manages properties; distributes medical instruments and equipment, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. It also manages medical project investment, consulting, and technology training activities; and manufactures medicines. Sinopharm Group Co. Ltd. was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
Q&A For Sinopharm Group Co. Ltd. Stock
What is a current SHTDY stock price?
Sinopharm Group Co. Ltd. SHTDY stock price today per share is 9.75 USD.
How to purchase Sinopharm Group Co. Ltd. stock?
You can buy SHTDY shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sinopharm Group Co. Ltd.?
The stock symbol or ticker of Sinopharm Group Co. Ltd. is SHTDY.
Which industry does the Sinopharm Group Co. Ltd. company belong to?
The Sinopharm Group Co. Ltd. industry is Medical Distribution.
How many shares does Sinopharm Group Co. Ltd. have in circulation?
The max supply of Sinopharm Group Co. Ltd. shares is 624.13M.
What is Sinopharm Group Co. Ltd. Price to Earnings Ratio (PE Ratio)?
Sinopharm Group Co. Ltd. PE Ratio is 5.76923040 now.
What was Sinopharm Group Co. Ltd. earnings per share over the trailing 12 months (TTM)?
Sinopharm Group Co. Ltd. EPS is 1.69 USD over the trailing 12 months.
Which sector does the Sinopharm Group Co. Ltd. company belong to?
The Sinopharm Group Co. Ltd. sector is Healthcare.
